- Home
- DSGR vs MNKD Comparison
DSGR vs MNKD Comparison
Compare DSGR & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSGR
- MNKD
- Stock Information
- Founded
- DSGR 1952
- MNKD 1991
- Country
- DSGR United States
- MNKD United States
- Employees
- DSGR N/A
- MNKD N/A
- Industry
- DSGR Industrial Machinery/Components
- MNKD Biotechnology: Pharmaceutical Preparations
- Sector
- DSGR Industrials
- MNKD Health Care
- Exchange
- DSGR Nasdaq
- MNKD Nasdaq
- Market Cap
- DSGR 1.7B
- MNKD 1.8B
- IPO Year
- DSGR N/A
- MNKD 2004
- Fundamental
- Price
- DSGR $38.08
- MNKD $6.85
- Analyst Decision
- DSGR Buy
- MNKD Strong Buy
- Analyst Count
- DSGR 2
- MNKD 5
- Target Price
- DSGR $43.00
- MNKD $8.40
- AVG Volume (30 Days)
- DSGR 44.9K
- MNKD 3.2M
- Earning Date
- DSGR 10-31-2024
- MNKD 11-07-2024
- Dividend Yield
- DSGR N/A
- MNKD N/A
- EPS Growth
- DSGR N/A
- MNKD N/A
- EPS
- DSGR 0.04
- MNKD 0.08
- Revenue
- DSGR $1,728,880,000.00
- MNKD $267,200,000.00
- Revenue This Year
- DSGR $16.08
- MNKD $46.83
- Revenue Next Year
- DSGR $12.01
- MNKD $14.40
- P/E Ratio
- DSGR $788.15
- MNKD $86.27
- Revenue Growth
- DSGR 15.72
- MNKD 51.35
- 52 Week Low
- DSGR $25.03
- MNKD $3.17
- 52 Week High
- DSGR $41.47
- MNKD $7.63
- Technical
- Relative Strength Index (RSI)
- DSGR 47.93
- MNKD 49.71
- Support Level
- DSGR $36.78
- MNKD $6.74
- Resistance Level
- DSGR $41.36
- MNKD $7.04
- Average True Range (ATR)
- DSGR 1.21
- MNKD 0.32
- MACD
- DSGR -0.18
- MNKD -0.06
- Stochastic Oscillator
- DSGR 50.97
- MNKD 24.94
About DSGR Distribution Solutions Group Inc.
Distribution Solutions Group Inc is an industrial distributor of maintenance and repair supplies. It has three operating segments namely Lawson, TestEquity, and Gexpro Services, of which key revenue is derived from the TestEquity segment. The TestEquity segment is a distributor of test and measurement equipment and solutions, electronic production supplies, and tool kits from its manufacturer partners supporting the technology, aerospace, defense, automotive, electronics, education, and medical industries.
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.